Archive for 2007

Herbert Boyer

It’s important to remember where the biotechnology industry comes from: the demonstration of gene splicing by Herbert Boyer and Stanley Cohen in 1973. Investor’s Business Daily has a great non-interview (Boyer doesn’t give interviews) profile of Boyer, retelling the story of Boyer’s meeting with Robert Swanson and the formation of Genentech, one of the first […]


Click here for reuse options!
Copyright 2007 Biotechblog

Functional Overview of the Biotechnology Industry

Here’s a slideshow of the presentation I give to students when I’m asked to give them a general introduction to the business of biotechnology. The material is drawn from my book, Building Biotechnology. Go ahead and post any questions you may have in the comments.


Click here for reuse options!
Copyright 2007 Biotechblog

Drug Patent Expirations in June 2007

Courtesy of DrugPatentWatch.com: Drug Patent Expirations in June 2007*Drugs may be covered by more than one patent Tradename Applicant Generic Name Patent Number Patent Expiration AEROBID Roche Palo flunisolide 4,933,168 JUN 12,2007 ANTHELIOS SX Loreal Usa avobenzone; ecamsule; octocrylene 4,585,597 JUN 16,2007 ESTRING Pharmacia And Upjohn estradiol 4,871,543 JUN 12,2007 ESTRING Pharmacia And Upjohn estradiol […]


Click here for reuse options!
Copyright 2007 Biotechblog

Carnival of Biotechnology

Welcome to the May 25th 2007 edition of Carnival of Biotechnology. Finance and business development The big news on the web is Google’s investment in 23andMe, described here by the California Biotech Law Blog. International biotech Business Week has an article on The Rush To Test Drugs In China. This is a story with a […]


Click here for reuse options!
Copyright 2007 Biotechblog

The global spread of biotechnology

I’ve been tracking the global spread of biotechnology for quite a while now. I’m fascinated with why biotechnology has taken root so strongly in the United States while many other countries are struggling to develop critical mass. This is the topic of a paper I’ve recently co-submitted in response to a request from the American […]


Click here for reuse options!
Copyright 2007 Biotechblog

A new journal in town…

If, like me, you miss the late Acumen Journal, you’ll be glad to hear that a very similar journal has launched. The Journal of Life Sciences brands itself “Where science and society meet.” A copy appeared in the mail a few weeks ago, and I’ve been meaning to post a blog about it. Now that […]


Click here for reuse options!
Copyright 2007 Biotechblog

Career Development at UNC Chapel Hill

I’ll be giving a talk on career development in biotechnology at UNC-Chapel Hill on Wednesday May 16th at 4pm in the Bioinformatics Building (ground floor auditorium), to be followed by a social/networking session at Top of the Hill (local brewery) at 5:30. My talk will open with my meandering career path, (hopefully) provide some guidance […]


Click here for reuse options!
Copyright 2007 Biotechblog

Greenpeace a champion for genetic modification?

What does Greenpeace oppose more: Patents, or genetic modification? This question has been answered in a recent patent case where the European Patent Office (EPO) rejected a Monsanto patent for a technique for genetic modification of plants. The patent, which was due to expire in 2008, describes a method to use a ‘particle gun’ to […]


Click here for reuse options!
Copyright 2007 Biotechblog

Top five biotechnology blogs

My article on the top five biotechnology blogs is up at Biotech360. Hope I don’t get too much hatemail over the blogs I didn’t mention; with a limit of five blogs I tried to identify one representative blog for policy, research, IP, marketing, and general innovation.


Click here for reuse options!
Copyright 2007 Biotechblog

Indian biotechnology: Full of promise, challenged by patents

India’s biotechnology industry has the potential to become a major driver of the country’s economy, but is challenged by one vital omission: patent protection. While current patent laws support a strong Indian generic industry, they also impede foreign investment. Without foreign investment India loses trading opportunities, and without a capacity to produce branded drugs India […]


Click here for reuse options!
Copyright 2007 Biotechblog

%d bloggers like this: